Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
pharmaphorum
22h
Sanofi's tolebrutinib cuts MS progression by 31% in trial
Data from the HERCULES trial presented at the ECTRIMS conference in Copenhagen, Denmark, today showed that tolebrutinib was ...
pharmaphorum
23h
J&J nets another key approval for blockbuster hope Rybrevant
J&J's high expectations for Rybrevant are driven mainly by its August approval with Lazcluze, which outperformed Tagrisso in ...
pharmaphorum
23h
5 patient travel strategies to impact enrolment diversity in clinical research
The challenge persists, but, with a renewed focus from regulatory bodies and trial sponsors alike on improving enrolment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Kentucky judge fatally shot
Secret Service probing post
$230 million crypto theft
Body found in SUV
Russia threatens retaliation
Disney to stop using Slack
Sesame Place suit verdict
Stein's ballot bid rejected
Drug price challenge revived
Recalling 449K+ vehicles
WI high court to decide
Baby powder recalled
Feds subpoena Schaeffer
MS sheriff's office probe
Bill to boost security OK'd
In-person voting begins
$3B for battery projects
Top Hezbollah leader killed?
144K+ Mavericks recalled
Sues pharmacy middlemen
Raises settlement offer
Hand count approved in GA
FDA approves flu vaccine
Jurors begin deliberations
House repeals emission rules
1st rabies outbreak in seals
Whooping cough cases spike
SC 1st execution in 13 years
Hiker injured in bear attack
Feedback